Elbit Imaging Ltd. (EMITF) Research

Headquartered in Petach Tikva, Israel, and established in 1996, Elbit Imaging Ltd. operates across North and South America, Europe, Asia, and Oceania. The company's primary focus involves the invention, manufacturing, and commercialization of therapeutic medical systems that enable non-invasive treatments of the human body, specifically utilizing ultrasound beam and magnetic resonance imaging technologies. Additionally, Elbit Imaging offers medical solutions based on stem cells, predominantly sourced from umbilical cord blood, which are crucial for bone marrow transplantations in individuals suffering from conditions such as leukemia, lymph node cancer, various non-malignant blood disorders, and inherited metabolic genetic diseases. The firm also has interests in real estate, engaging in the sale of land plots and high-end villas within India.

Market snapshot

Symbol
EMITF
Price
$1.60
Day change
0.00%
Market cap
$81.5M
P/E ratio
-12.27x
52-week range
0.05-2.15
Sector
Healthcare
Industry
Medical - Devices

Peer companies

  • Aurora Spine Corporation (ASAPF)
  • Biotricity, Inc. (BTCY)
  • Guided Therapeutics, Inc. (GTHP)
  • ImpediMed Limited (IPDQF)
  • Isracann Biosciences Inc. (ISCNF)
  • Izotropic Corporation (IZOZF)
  • Positron Corporation (POSC)
  • Perimeter Medical Imaging AI, Inc. (PYNKF)

Open Elbit Imaging Ltd. (EMITF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.